HRP20080602T3 - Amidometil-supstituirani derivati 2-(4-sulfonilamin)-3,4-dihidro-2h-kromen-6, postupci njihovog dobivanja i međuproizvodi, te lijekovi koji sadrže teveze - Google Patents

Amidometil-supstituirani derivati 2-(4-sulfonilamin)-3,4-dihidro-2h-kromen-6, postupci njihovog dobivanja i međuproizvodi, te lijekovi koji sadrže teveze

Info

Publication number
HRP20080602T3
HRP20080602T3 HR20080602T HRP20080602T HRP20080602T3 HR P20080602 T3 HRP20080602 T3 HR P20080602T3 HR 20080602 T HR20080602 T HR 20080602T HR P20080602 T HRP20080602 T HR P20080602T HR P20080602 T3 HRP20080602 T3 HR P20080602T3
Authority
HR
Croatia
Prior art keywords
alkyl
substituted
phenyl
sulfonilamino
hidroxy
Prior art date
Application number
HR20080602T
Other languages
English (en)
Inventor
Sykes David
Moloney Brian
Marrison Lester
Ziegler Dieter
Mlinaric Michael
Boecker Christiane
Brueckner Reinhard
Weske Michael
Witte Klaus
Fischer Yvan
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of HRP20080602T3 publication Critical patent/HRP20080602T3/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Veze opće formule I, gdjeR1 znači C1-4 -alkilR2 znači C1-4 - alkilR3 znači fenil, koji je u danomslučaju jednostruko do dvostruko supstituiran halogenom, C1-4 - alkilom, C1-4 - alkoksom ili trifluormetilom; naftil ili bifenilR4 znači vodik; C1-6- alkil ili C3-7 - cikloalkil- C1-4 - alkilR5 znači vodikR6 znači C1-6 - alkil; fenil- C1-4 -alkil, čija je fenilna grupa u danom slučaju jednostruko supstituirana halogenom; furil- C1-4 -alkil ilitetrahidronaftilR5 i R6 zajedno s dušikom, na koji su vezani, tvore piperazin prsten, koji je u danom slučaju supstituiran fenilom. Patent sadrži još10 patentnih zahtjeva.
HR20080602T 2003-10-17 2008-11-20 Amidometil-supstituirani derivati 2-(4-sulfonilamin)-3,4-dihidro-2h-kromen-6, postupci njihovog dobivanja i međuproizvodi, te lijekovi koji sadrže teveze HRP20080602T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10348298A DE10348298A1 (de) 2003-10-17 2003-10-17 Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
PCT/EP2004/052539 WO2005037780A2 (de) 2003-10-17 2004-10-14 Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
HRP20080602T3 true HRP20080602T3 (hr) 2008-12-31

Family

ID=34442032

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080602T HRP20080602T3 (hr) 2003-10-17 2008-11-20 Amidometil-supstituirani derivati 2-(4-sulfonilamin)-3,4-dihidro-2h-kromen-6, postupci njihovog dobivanja i međuproizvodi, te lijekovi koji sadrže teveze

Country Status (25)

Country Link
EP (1) EP1678130B1 (hr)
JP (1) JP4791968B2 (hr)
KR (1) KR20060129170A (hr)
CN (1) CN100532375C (hr)
AR (1) AR046106A1 (hr)
AT (1) ATE405547T1 (hr)
AU (1) AU2004281195B2 (hr)
BR (1) BRPI0415523A (hr)
CA (1) CA2542813C (hr)
DE (3) DE10348298A1 (hr)
DK (1) DK1678130T3 (hr)
ES (1) ES2313126T3 (hr)
HK (1) HK1096960A1 (hr)
HR (1) HRP20080602T3 (hr)
IL (1) IL174950A (hr)
MX (1) MXPA06003958A (hr)
NO (1) NO20062202L (hr)
PL (1) PL1678130T3 (hr)
PT (1) PT1678130E (hr)
RU (1) RU2355685C2 (hr)
SI (1) SI1678130T1 (hr)
TW (1) TWI321564B (hr)
UA (1) UA82907C2 (hr)
WO (1) WO2005037780A2 (hr)
ZA (1) ZA200602788B (hr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871758B1 (en) * 2005-04-12 2010-08-25 Abbott Products GmbH Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
JP4943429B2 (ja) * 2005-07-22 2012-05-30 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
NO3175985T3 (hr) 2011-07-01 2018-04-28
CA2862670A1 (en) 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012173A1 (en) * 1992-11-30 1994-06-09 Smithkline Beecham Plc Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
CA2341678C (en) * 1998-09-01 2009-10-13 Bristol-Myers Squibb Company Potassium channel inhibitors and method
AU2830800A (en) * 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
JP2000336085A (ja) * 1999-03-25 2000-12-05 Nissan Chem Ind Ltd クロマン誘導体
US6458794B2 (en) * 1999-12-21 2002-10-01 Icagen, Inc. Potassium channel inhibitors

Also Published As

Publication number Publication date
HK1096960A1 (en) 2007-06-15
WO2005037780A2 (de) 2005-04-28
SI1678130T1 (sl) 2008-12-31
DE10348298A1 (de) 2005-05-19
EP1678130A2 (de) 2006-07-12
ZA200602788B (en) 2008-01-30
UA82907C2 (en) 2008-05-26
DE112004001659D2 (de) 2006-08-10
JP2007516235A (ja) 2007-06-21
EP1678130B1 (de) 2008-08-20
KR20060129170A (ko) 2006-12-15
IL174950A0 (en) 2006-08-20
JP4791968B2 (ja) 2011-10-12
PT1678130E (pt) 2008-10-08
AU2004281195A2 (en) 2005-04-28
RU2355685C2 (ru) 2009-05-20
AR046106A1 (es) 2005-11-23
WO2005037780A3 (de) 2007-10-18
CA2542813C (en) 2011-08-30
RU2006116629A (ru) 2007-11-27
IL174950A (en) 2010-06-30
AU2004281195B2 (en) 2010-12-16
CN100532375C (zh) 2009-08-26
DE502004007916D1 (de) 2008-10-02
CN1894233A (zh) 2007-01-10
TW200523259A (en) 2005-07-16
BRPI0415523A (pt) 2006-12-26
ATE405547T1 (de) 2008-09-15
NO20062202L (no) 2006-07-03
DK1678130T3 (da) 2008-12-01
TWI321564B (en) 2010-03-11
AU2004281195A1 (en) 2005-04-28
ES2313126T3 (es) 2009-03-01
PL1678130T3 (pl) 2009-01-30
MXPA06003958A (es) 2006-07-05
CA2542813A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
HRP20080602T3 (hr) Amidometil-supstituirani derivati 2-(4-sulfonilamin)-3,4-dihidro-2h-kromen-6, postupci njihovog dobivanja i međuproizvodi, te lijekovi koji sadrže teveze
UY26943A1 (es) Derivados de piridina
HRP20070286T3 (hr) Supstituirani diketopiperazini i njihova upotrebakao oksitocinski antagonisti
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
HN2002000300A (es) Nuevos derivados de piperazina
CR8193A (es) Piperazina con o sustituida de grupos feniles y su uso como inhibidores de glyt 1
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
ATE302775T1 (de) Carbolinderivate
BR0211473A (pt) Novos compostos
EA201100877A1 (ru) Спирогетероциклические n-оксиамиды в качестве пестицидов
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
MEP53708A (hr) 3-z-[1-(4-(n-((4-metil-piperazin-1-il) -metilkarbonil) -n-metil-amino) -anilino)-1- fenil-metilen] -6-metoksikarbonil-2 -indolinon- monoetansulfonat i njegova primjena u farmaceutskoj kompoziciji
DK1188747T3 (da) Phenoxypropylaminforbindelser
UY26721A1 (es) Nuevos derivados de la fenilglicina
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
ATE346067T1 (de) Carbolinderivate
PA8576001A1 (es) "difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion , medicamentos que comprenden estos compuestos y su uso".
RS53428B (en) COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES
DK1585493T3 (da) Triazinderivater som UV-absorbenter
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200800070A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина
TR200400645T4 (tr) İkameli Fenil Piperazin türevleri, Bunların Hazırlanması ve kullanımları
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren